Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
Journal of Neurointerventional Surgery|April 17, 2020
Early repatriation post-thrombectomy: a model of care which maximises the capacity of a stroke network to treat patients with large vessel ischaemic strokeEmma Griffin, Sean Murphy, Mark Sheehan, et al.
Neurology|April 15, 2014
Serum lipids associated with inflammation-related PET-FDG uptake in symptomatic carotid plaqueDanielle Ní Chróinín, Michael Marnane, Layan Akijian, et al.
Blood Pressure Monitoring|November 21, 2008
Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at homeJan A Staessen, Lutgarde Thijs, Takayoshi Ohkubo, et al.
BMJ Open|July 22, 2020
Cohort profile: BIOVASC-late, a prospective multicentred study of imaging and blood biomarkers of carotid plaque inflammation and risk of late vascular recurrence after non-severe stroke in IrelandJohn Joseph McCabe, Nicola Giannotti, Jonathan McNulty, et al.
Neurology|December 18, 2024
Clinical and Biomarker Determinants for Recurrent Stroke in Patients With Atrial Fibrillation: A Systematic Review and Meta-AnalysisYuen Cheung, Marianne Foley, David Bradley, et al.
Annals of Neurology|March 31, 2012
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrenceMichael Marnane, Aine Merwick, Orla C Sheehan, et al.
European Stroke Journal|July 22, 2023
Symptomatic Carotid Atheroma Inflammation Lumen-stenosis score compared with Oxford and Essen risk scores to predict recurrent stroke in symptomatic carotid stenosisSarah Gorey, John J McCabe, Pol Camps-Renom, et al.
Lancet (London, England)|April 11, 2003
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Drugs|March 16, 2005
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Diabetes Care|April 28, 2005
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.
Pageof 23